The present invention relates to the gemcitabine prodrug 1-(2,2-difluoro-2-deoxy-.beta.-D -ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one useful as an oral drug for the treatment of cancer.

 
Web www.patentalert.com

< RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

> Structure designed for adsorption of DNA intercalators

> In vivo production of small interfering RNAS that mediate gene silencing
~ 00595